Zekui Wu

1.4k total citations
21 papers, 1.2k citations indexed

About

Zekui Wu is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Zekui Wu has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Zekui Wu's work include Immunotherapy and Immune Responses (16 papers), vaccines and immunoinformatics approaches (6 papers) and T-cell and B-cell Immunology (6 papers). Zekui Wu is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), vaccines and immunoinformatics approaches (6 papers) and T-cell and B-cell Immunology (6 papers). Zekui Wu collaborates with scholars based in United States, Israel and Singapore. Zekui Wu's co-authors include David Avigan, Donald Küfe, Jianlin Gong, Dongshu Chen, Baldev Vasir, Shigeo Koido, Jacalyn Rosenblatt, Masahiro Kashiwaba, Kenneth C. Anderson and Lynne Uhl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Zekui Wu

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zekui Wu United States 13 853 607 556 204 113 21 1.2k
Jonathan Skipper United States 12 1.7k 2.0× 551 0.9× 919 1.7× 197 1.0× 216 1.9× 16 2.0k
Wouter Scheper Netherlands 11 924 1.1× 773 1.3× 310 0.6× 98 0.5× 95 0.8× 15 1.3k
Robin Pennington United States 10 896 1.1× 486 0.8× 334 0.6× 74 0.4× 242 2.1× 12 1.2k
Jake Y. Henry United Kingdom 12 1.1k 1.3× 1.1k 1.9× 411 0.7× 384 1.9× 145 1.3× 18 1.7k
William Hallett United States 11 513 0.6× 498 0.8× 328 0.6× 293 1.4× 230 2.0× 16 1.0k
Yutaka Kawakami Japan 17 672 0.8× 452 0.7× 331 0.6× 52 0.3× 191 1.7× 31 1.2k
Tatyana Korontsvit United States 19 906 1.1× 878 1.4× 589 1.1× 453 2.2× 228 2.0× 31 1.7k
Achim Rothe Germany 21 693 0.8× 763 1.3× 469 0.8× 143 0.7× 476 4.2× 41 1.7k
Juan J. Pérez‐Villar Spain 18 1.7k 2.0× 592 1.0× 315 0.6× 87 0.4× 74 0.7× 24 2.0k
Herschel Wallen United States 7 715 0.8× 713 1.2× 580 1.0× 107 0.5× 31 0.3× 7 1.4k

Countries citing papers authored by Zekui Wu

Since Specialization
Citations

This map shows the geographic impact of Zekui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zekui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zekui Wu more than expected).

Fields of papers citing papers by Zekui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zekui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zekui Wu. The network helps show where Zekui Wu may publish in the future.

Co-authorship network of co-authors of Zekui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zekui Wu. A scholar is included among the top collaborators of Zekui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zekui Wu. Zekui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Zekui, et al.. (2022). Gyrification structure of Si–Al thin film anodes with high-rate performance. Materials Science in Semiconductor Processing. 151. 106981–106981. 3 indexed citations
2.
Vasir, Baldev, Corrine Zarwan, Rehan Ahmad, et al.. (2012). Induction of Antitumor Immunity Ex Vivo Using Dendritic Cells Transduced With Fowl Pox Vector Expressing MUC1, CEA, and a Triad of Costimulatory Molecules (rF-PANVAC). Journal of Immunotherapy. 35(7). 555–569. 8 indexed citations
3.
Rosenblatt, Jacalyn, Zekui Wu, Baldev Vasir, et al.. (2010). Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28. Journal of Immunotherapy. 33(2). 155–166. 23 indexed citations
4.
Rosenblatt, Jacalyn, Baldev Vasir, Lynne Uhl, et al.. (2010). Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma. Blood. 117(2). 393–402. 169 indexed citations
5.
Raina, Deepak, Rehan Ahmad, Maya Datt Joshi, et al.. (2009). Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells. Cancer Research. 69(12). 5133–5141. 125 indexed citations
7.
Rosenblatt, Jacalyn, Brett Glotzbecker, Heidi Mills, et al.. (2009). CT-011, Anti-PD-1 Antibody, Enhances Ex-Vivo T Cell Responses to Autologous Dendritic/Myeloma Fusion Vaccine Developed for the Treatment of Multiple Myeloma.. Blood. 114(22). 781–781. 5 indexed citations
9.
Rosenblatt, Jacalyn, Zekui Wu, Baldev Vasir, et al.. (2008). Immunomodulatory Effects of Vitamin D: Implications for the Prevention and Treatment of Graft Versus Host Disease. Blood. 112(11). 1251–1251. 1 indexed citations
10.
Kawano, Takeshi, Masaki Ito, Deepak Raina, et al.. (2007). MUC1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells. Cancer Research. 67(24). 11576–11584. 34 indexed citations
11.
Avigan, David, Jacalyn Rosenblatt, Baldev Vasir, et al.. (2007). Vaccination with DC/Multiple Myeloma Fusions in Conjunction with Stem Cell Transplantation.. Blood. 110(11). 578–578. 1 indexed citations
12.
Avigan, David, Jacalyn Rosenblatt, Baldev Vasir, et al.. (2007). Phase I Study of Vaccination with Dendritic Cell Myeloma Fusions.. Blood. 110(11). 284–284. 2 indexed citations
13.
Vasir, Baldev, David Avigan, Zekui Wu, et al.. (2005). Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-Dependent Mechanism. The Journal of Immunology. 174(4). 2376–2386. 26 indexed citations
14.
Vasir, Baldev, Virginia F. Borges, Zekui Wu, et al.. (2005). Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation. British Journal of Haematology. 129(5). 687–700. 47 indexed citations
15.
Avigan, David, Baldev Vasir, Jianlin Gong, et al.. (2004). Fusion Cell Vaccination of Patients with Metastatic Breast and Renal Cancer Induces Immunological and Clinical Responses. Clinical Cancer Research. 10(14). 4699–4708. 203 indexed citations
16.
Avigan, David, Baldev Vasir, Zekui Wu, et al.. (2004). Dendritic Cell Myeloma Fusions Stimulate Anti-Tumor Immunity: Results from Pre-Clinical Studies and a Clinical Trial.. Blood. 104(11). 751–751. 4 indexed citations
17.
Gong, Jianlin, Najmosama Nikrui, Dongshu Chen, et al.. (2000). Fusions of Human Ovarian Carcinoma Cells with Autologous or Allogeneic Dendritic Cells Induce Antitumor Immunity. The Journal of Immunology. 165(3). 1705–1711. 184 indexed citations
18.
Gong, Jianlin, David Avigan, Dongshu Chen, et al.. (2000). Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proceedings of the National Academy of Sciences. 97(6). 2715–2718. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026